S. Butt,M. Idrees, H. Akbar et al., “The changing epidemiology pattern and frequency distribution of hepatitis C virus in Pakistan,” Infection, Genetics and Evolution, vol. 10, no. 5, pp.595–600, 2010.  M. Idrees, S. Rafique, I. Rehman et al., “Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience,” World Journal of Gastroenterology, vol. 15, no. 40, pp. 5080–5085, 2009.  M. J. Alter, “Epidemiology of hepatitis C virus infection,” World Journal of Gastroenterology, vol. 13, no. 17, pp. 2436–2441, 2007.  A. Hatzakis, S. Wait, J. Bruix et al., “The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference,” Journal of Viral Hepatitis, vol. 18, no. 1, pp. 1–16, 2011.
 C. H. Hagedorn, E.H. van Beers, andC. de Staercke, “Hepatitis C virus RNA-dependent RNA polymerase (NS5B polymerase),” Current Topics inMicrobiology and Immunology, vol. 242, p. 327, 2000.  N. Kato, “Molecular virology of hepatitis C virus,” Acta Medica Okayama, vol. 55, no. 3, pp. 133–159, 2001.  M. Liew, M. Erali, S. Page, D. Hillyard, and C. Wittwer, “Hepatitis C genotyping by denaturing high-performance liquid chromatography,” Journal of Clinical Microbiology, vol. 42, no. 1, pp. 158–163, 2004.  M. Idrees, A. Lal, M. Naseem, and M. Khalid, “High prevalence of hepatitis C virus infection in the largest province of Pakistan,” Journal of Digestive Diseases, vol. 9, no. 2, pp. 95–103, 2008.  A. R. N. Zekri, A. A. Bahnassy, H. M. A. El-Din, and H. M. Salama, “Consensus siRNA for inhibition of HCV genotype-4 replication,” Virology Journal, vol. 6, article 13, 2009.  R.W.Chamberlain,N.Adams, A. A. Saeed, P. Simmonds, and R.M. Elliott, “Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East,” Journal of General Virology, vol. 78, no. 6, pp. 1341–1347, 1997.  A. S. Abdulkarim, N. N. Zein, J. J. Germer et al., “Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes,” The American Journal of Tropical Medicine and Hygiene, vol. 59, no. 4, pp. 571–576, 1998.  N.N. Zein, “Clinical significance of hepatitisCvirus genotypes,” Clinical Microbiology Reviews, vol. 13, no. 2, pp. 223–235, 2000.  D. Amarapurkar, M. Dhorda, A. Kirpalani, A. Amarapurkar, and S. Kankonkar, “Prevalence of hepatitis C genotypes in Indian patients and their clinical significance,” Journal of Association of Physicians of India, vol. 49, pp. 983–985, 2001.  S. Singh, V.Malhotra, and S. K. Sarin, “Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in India,” Indian Journal of Medical Research, vol. 119, no. 4, pp.145–148, 2004.  I. Rehman,M. Idrees, M. Ali et al., “Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan,” Genetic Vaccines and Therapy, vol. 9, article 2, 2011.
 H. Okamoto, Y. Sugiyama, S. Okada et al., “Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources,” Journal of General Virology, vol. 73, no. 3, pp. 673–679, 1992.  A. Ali, H. Ahmed, and M. Idrees, “Molecular epidemiology of Hepatitis C virus genotypes in Khyber Pakhtoonkhaw of Pakistan,” Virology Journal, vol. 7, pp. 203–210, 2010.  I. M. Idrees, H. Ahmed, M. Ali, L. Ali, and A. Ahmed, “Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan,” Virology Journal, vol. 8, article 16, 2011.  A. Z. Safi, Y. Waheed, J. Sadat, S. Salahuddin, U. Saeed, and M. Ashraf, “Molecular study of HCV detection, genotypes and their routes of transmission in North West Frontier Province, Pakistan,” Asian Pacific Journal of Tropical Biomedicine, vol. 2, no. 7, pp. 532–536, 2012.  S. Q. Afridi, M. N. Zahid, M. Z. Shabbir et al., “Prevalence of HCV genotypes in district Mardan,” Virology Journal, vol. 10, article 90, 2013.
 D. B. Strader,T.Wright, D. L.Thomas, and L. B. Seeff, “Diagnosis, management, and treatment of hepatitis C,” Hepatology, vol.39, no. 4, pp. 1147–1171, 2004.  S. Klimashevskaya, A. Obriadina, T. Ulanova et al., “Distinguishing acute from chronic and resolved hepatitis C virus (HCV) infections by measurement of anti-HCV immunoglobulin G avidity index,” Journal of Clinical Microbiology, vol. 45, no. 10, pp. 3400–3403, 2007.  A. C. Araujo, I. V. Astrakhantseva, H. A. Fields, and S.Kamili, “Distinguishing acute from chronic hepatitis C virus (HCV) infection based on antibody reactivities to specific HCV structural and nonstructural proteins,” Journal of Clinical Microbiology, vol. 49, no. 1, pp. 54–57, 2011.  L. Stuyver, W. van Arnhem, A. Wyseur, F. Hernandez, E. Delaporte, and G. Maertens, “Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 21, pp. 10134– 10138, 1994.  J. Bukh, R. H. Miller, and R. H. Purcell, “Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes,” Seminars in Liver Disease, vol. 15, no. 1, pp. 41–63, 1995.
 T. Sy and M. M. Jamal, “Epidemiology of hepatitis C virus (HCV) infection,” International Journal ofMedical Sciences, vol. 3, no. 2, pp. 41–46, 2006.  J. Pawlotsky, “Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C,” Antiviral Research, vol. 59, no. 1,pp. 1–11, 2003.  M.Nafees, M. S. Bhatti, and I.U.Haq, “Sero-prevalence of HCV Antibodies in population attending Madina Teaching hospital, Faisalabad,” Annals of King Edward Medical University, vol. 13, no. 4, pp. 57–62, 2010.  S. Akhtar, T. Moatter, S. I. Azam, M. H. Rahbar, and S. Adil, “Prevalence and risk factors for intrafamilial transmission of hepatitis C virus in Karachi, Pakistan,” Journal of ViralHepatitis, vol. 9, no. 4, pp. 309–314, 2002.  N. S. Ali, K. Jamal, and R. Qureshi, “Hepatitis B vaccination status and identification of risk factors for hepatitis B in health care workers,” Journal of the College of Physicians and Surgeons. Pakistan, vol. 15, no. 5, pp. 257–260, 2005. . Ryan KJ, Ray CG: Sherris medical microbiology. New York: McGraw Hill; 2004:551–552. . Grobusch MP, Alpermann U, Schwenke S, Jelinek T, Warhurst DC: Falsepositive rapid tests for malaria in patients with rheumatoid factor. Lancet 1999, 353:297. . Rizzetto M: Viral hepatitis: introduction. In Oxford Textbook of Clinical Hepatology. Edited by McIntyre N, Benhamou JP, Bicher J, Rizzeto M, Rodes J. Oxford: Oxford Medical Publication; 1992:529. . World Health Organization Hepatitis C: Fact sheet No. 164°. Geneva: Switzerland; 2011. . Ahmad N, Asgher M, Shafique M, Qureshi JA: An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan. Saudi Med J 2007, 28:390–395. . Aslam M, Aslam J: Seroprevalence of the antibody to hepatitis C in select groups in the Punjab region of Pakistan. J Clin Gastroenterol 2001, 33:407–411.